Bayer expects earnings to decline further next year due to weak agricultural markets, causing a sharp drop in its shares. CEO Bill Anderson is implementing cost-cutting measures to revive the company. Despite challenges, he remains optimistic about Bayer's future.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing